Oculis Holding AG
Clinical-stage biopharma developing therapies for ophthalmic and neuro-ophthalmic diseases.
OCS | IC
Overview
Corporate Details
- ISIN(s):
- CH1242303498 (+1 more)
- LEI:
- 5067005370C2KK324336
- Country:
- Switzerland
- Address:
- Bahnhofstrasse 7, 6300 Zug
- Website:
- https://www.oculis.com/
- Sector:
- Manufacturing
Description
Oculis Holding AG is a global, clinical-stage biopharmaceutical company focused on developing innovative therapies for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs. The company's pipeline aims to transform current treatment paradigms. Key candidates include OCS-01, a topical eye drop using the proprietary OPTIREACH® technology, investigated as a potential first non-invasive treatment for Diabetic Macular Edema (DME). Another lead asset is Privosegtor, a novel peptoid small molecule being developed as a neuroprotective therapy for optic neuropathies such as Acute Optic Neuritis. The pipeline also features Licaminlimab, an anti-TNFα eye drop candidate for treating Dry Eye Disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-10 09:00 |
Oculis Completes Enrollment in both..
|
Icelandic | 14.5 KB | ||
| 2025-04-10 09:00 |
Oculis Completes Enrollment in both..
|
English | 12.9 KB | ||
| 2025-04-09 22:00 |
Oculis Publishes Notifications of T..
|
English | 984.9 KB | ||
| 2025-04-01 09:00 |
Oculis to Host In-Person and Virtua..
|
English | 16.4 KB | ||
| 2025-03-20 22:00 |
Oculis Publishes Notifications of T..
|
English | 1021.7 KB | ||
| 2025-03-14 20:31 |
Oculis Publishes Notifications of T..
|
English | 1.0 MB | ||
| 2025-03-11 20:30 |
Oculis Reports Q4 and Full Year 202..
|
Icelandic | 248.8 KB | ||
| 2025-03-11 20:30 |
Oculis Reports Q4 and Full Year 202..
|
English | 523.2 KB | ||
| 2025-03-11 20:30 |
Oculis Reports Q4 and Full Year 202..
|
English | 227.2 KB | ||
| 2025-03-11 20:30 |
Oculis Reports Q4 and Full Year 202..
|
English | 523.2 KB | ||
| 2025-03-11 20:30 |
Oculis Reports Q4 and Full Year 202..
|
English | 1.4 MB | ||
| 2025-03-11 20:30 |
Oculis Reports Q4 and Full Year 202..
|
English | 288.6 KB | ||
| 2025-03-11 20:30 |
Oculis Reports Q4 and Full Year 202..
|
English | 227.2 KB | ||
| 2025-03-03 08:18 |
Oculis Publishes Notifications of T..
|
English | 1021.4 KB | ||
| 2025-02-14 00:40 |
Oculis Announces Pricing of $100 Mi..
|
Icelandic | 10.4 KB |
Automate Your Workflow. Get a real-time feed of all Oculis Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oculis Holding AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oculis Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
